176 related articles for article (PubMed ID: 35499617)
1. Proton pump inhibitors use and risk of incident nephrolithiasis.
Sui W; Miller NL; Gould ER; Zhang KC; Koyama T; Hsi RS
Urolithiasis; 2022 Aug; 50(4):401-409. PubMed ID: 35499617
[TBL] [Abstract][Full Text] [Related]
2. Use of Proton Pump Inhibitors Increases Risk of Incident Kidney Stones.
Simonov M; Abel EA; Skanderson M; Masoud A; Hauser RG; Brandt CA; Wilson FP; Laine L
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):72-79.e21. PubMed ID: 32147588
[TBL] [Abstract][Full Text] [Related]
3. Proton-pump inhibitors associated with decreased urinary citrate excretion.
Patel PM; Kandabarow AM; Aiwerioghene E; Blanco-Martinez E; Hart S; Leehey DJ; Farooq A; Baldea KG; Turk TMT
Int Urol Nephrol; 2021 Apr; 53(4):679-683. PubMed ID: 33206338
[TBL] [Abstract][Full Text] [Related]
4. Risk of urinary stone formation associated to proton pump inhibitors: A systematic review and metanalysis.
Bapir R; Bhatti KH; Eliwa A; García-Perdomo HA; Gherabi N; Hennessey D; Magri V; Mourmouris P; Ouattara A; Perletti G; Philipraj J; Stamatiou K; Adetola Tolani M; Tzelves L; Trinchieri A; Buchholz N
Arch Ital Urol Androl; 2022 Dec; 94(4):507-514. PubMed ID: 36576453
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.
Chen CH; Lin CL; Kao CH
Osteoporos Int; 2016 Jun; 27(6):2117-26. PubMed ID: 26860609
[TBL] [Abstract][Full Text] [Related]
6. Association of proton pump inhibitor use with risk of kidney stones: an analysis of cross-sectional data from the US National Health and Nutrition Examination Survey (2007-2018).
Liu W; Wang J; Wang M; Wang M; Liu M
BMJ Open; 2023 Oct; 13(10):e075136. PubMed ID: 37844987
[TBL] [Abstract][Full Text] [Related]
7. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
8. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) Study.
Rooney MR; Bell EJ; Alonso A; Pankow JS; Demmer RT; Rudser KD; Chen LY; Lutsey PL
J Clin Gastroenterol; 2021 Sep; 55(8):677-683. PubMed ID: 33471493
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor prescriptions and subsequent use in US veterans diagnosed with gastroesophageal reflux disease.
Gawron AJ; Pandolfino JE; Miskevics S; Lavela SL
J Gen Intern Med; 2013 Jul; 28(7):930-7. PubMed ID: 23400526
[TBL] [Abstract][Full Text] [Related]
12. Association between gastroesophageal reflux disease and coronary heart disease: A nationwide population-based analysis.
Chen CH; Lin CL; Kao CH
Medicine (Baltimore); 2016 Jul; 95(27):e4089. PubMed ID: 27399102
[TBL] [Abstract][Full Text] [Related]
13. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
[TBL] [Abstract][Full Text] [Related]
14. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.
Shi YC; Cai ST; Tian YP; Zhao HJ; Zhang YB; Chen J; Ren RR; Luo X; Peng LH; Sun G; Yang YS
Genomics Proteomics Bioinformatics; 2019 Feb; 17(1):52-63. PubMed ID: 31028880
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
Takeuchi T; Hongo H; Kimura T; Kojima Y; Harada S; Ota K; Takeuchi N; Noguchi T; Inoue T; Murano M; Higuchi K
J Gastroenterol; 2019 Nov; 54(11):972-983. PubMed ID: 31037449
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of treatment pattern and symptom control in patients with gastroesophageal reflux disease: multihospital questionnaire survey on the current situation in Korea.
Seo SI; Bang CS; Kang HS; Choi MH; Shin WG; Jang HJ; Kim JB; Baik KH; Kae SH; Kim HY
Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859382
[TBL] [Abstract][Full Text] [Related]
18. Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations.
Vakil N; Niklasson A; Denison H; Rydén A
BMC Gastroenterol; 2014 Oct; 14():177. PubMed ID: 25304129
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.
Spechler SJ
Gastroenterol Clin North Am; 2020 Sep; 49(3):437-450. PubMed ID: 32718563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
